Results 1 - 20 of 518 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (488)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsThe New England journal of medicine, 2008-09, Vol.359 (12), p.1225-1237 [Peer Reviewed Journal]Copyright © 2008 Massachusetts Medical Society. All rights reserved. ;2008 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2008 Massachusetts Medical Society. All rights reserved. 2008 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0804593 ;PMID: 18753639 ;CODEN: NEJMAGFull text available |
| 2 |
Material Type: Article
|
|
Eltrombopag Added to Standard Immunosuppression for Aplastic AnemiaThe New England journal of medicine, 2017-04, Vol.376 (16), p.1540-1550 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1613878 ;PMID: 28423296Full text available |
| 3 |
Material Type: Article
|
|
Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trialHaematologica (Roma), 2020-03, Vol.105 (3), p.820-828 [Peer Reviewed Journal]Copyright© 2020 Ferrata Storti Foundation. ;Copyright© 2020 Ferrata Storti Foundation 2020 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2019.223966 ;PMID: 31273088Full text available |
| 4 |
Material Type: Article
|
|
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND studyBlood, 2017-12, Vol.130 (23), p.2527-2536 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-04-748707 ;PMID: 29042367Full text available |
| 5 |
Material Type: Article
|
|
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeHaematologica (Roma), 2020-12, Vol.105 (12), p.2785-2794 [Peer Reviewed Journal]Copyright© 2020 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2020.249995 ;PMID: 33256377Full text available |
| 6 |
Material Type: Article
|
|
Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaThe New England journal of medicine, 2022-01, Vol.386 (1), p.11-23 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2109965 ;PMID: 34986284Full text available |
| 7 |
Material Type: Article
|
|
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood, 2014-03, Vol.123 (12), p.1818-1825 [Peer Reviewed Journal]2014 American Society of Hematology ;The publisher or recipient acknowledges right of the US government to retain a nonexclusive, royalty-free license in and to any copyright covering the article. 2014 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2013-10-534743 ;PMID: 24345753Full text available |
| 8 |
Material Type: Article
|
|
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsThe Lancet (British edition), 2017-06, Vol.389 (10085), p.2226-2237 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 3, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30754-7 ;PMID: 28390695Full text available |
| 9 |
Material Type: Article
|
|
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialThe Lancet (British edition), 2015-10, Vol.386 (10004), p.1649-1658 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 24, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)61107-2 ;PMID: 26231455 ;CODEN: LANCAOFull text available |
| 10 |
Material Type: Article
|
|
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopeniaBlood, 2018-12, Vol.132 (25), p.2629-2638 [Peer Reviewed Journal]2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-06-855221 ;PMID: 30305280Full text available |
| 11 |
Material Type: Article
|
|
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter studyBlood, 2020-12, Vol.136 (26), p.3056-3061 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007594 ;PMID: 32814348Full text available |
| 12 |
Material Type: Article
|
|
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND studyBlood, 2013-01, Vol.121 (3), p.537-545 [Peer Reviewed Journal]2013 American Society of Hematology ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-04-425512 ;PMID: 23169778Full text available |
| 13 |
Material Type: Article
|
|
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic AnemiaThe New England journal of medicine, 2012-07, Vol.367 (1), p.11-19 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2012 Massachusetts Medical Society. 2012 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1200931 ;PMID: 22762314 ;CODEN: NEJMAGFull text available |
| 14 |
Material Type: Article
|
|
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuriaBlood, 2020-07, Vol.136 (1), p.36-49 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000940 ;PMID: 32430502Full text available |
| 15 |
Material Type: Article
|
|
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trialThe Lancet (British edition), 2008-09, Vol.372 (9644), p.1174-1183 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Sep 27-Oct 3, 2008 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61242-8 ;PMID: 18757085 ;CODEN: LANCAOFull text available |
| 16 |
Material Type: Article
|
|
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trialsThe lancet oncology, 2010-07, Vol.11 (7), p.627-636 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 2010 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(10)70106-6 ;PMID: 20542468 ;CODEN: LANCAOFull text available |
| 17 |
Material Type: Article
|
|
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialThe Lancet (British edition), 2008-08, Vol.372 (9638), p.547-553 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Aug 16-Aug 22, 2008 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61236-2 ;PMID: 18707986 ;CODEN: LANCAOFull text available |
| 18 |
Material Type: Article
|
|
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 TrialAmerican journal of ophthalmology, 2019-11, Vol.207, p.248-257 [Peer Reviewed Journal]2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. ;2019. The Author(s) ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2019.06.016 ;PMID: 31229466Full text available |
| 19 |
Material Type: Article
|
|
Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)American journal of ophthalmology, 2019-04, Vol.200, p.130-137 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2019.01.003 ;PMID: 30653957Full text available |
| 20 |
Material Type: Article
|
|
Eltrombopag before Procedures in Patients with Cirrhosis and ThrombocytopeniaThe New England journal of medicine, 2012-08, Vol.367 (8), p.716-724 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1110709 ;PMID: 22913681 ;CODEN: NEJMAGFull text available |
Results 1 - 20 of 518 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (488)
Refine My Results
Creation Date
- Before 1977 (39)
- 1977 To 1987 (39)
- 1988 To 1998 (56)
- 1999 To 2010 (152)
- After 2010 (234)
-
More options
New Records
Resource Type
- Articles (517)
- magazinearticle (1)
-
More options
Subject
- Benzoates - Adverse Effects (496)
- Humans (496)
- Science & Technology (464)
- Life Sciences & Biomedicine (458)
- Male (326)
- Female (304)
- Adult (239)
- Middle Aged (226)
- Benzoates - Therapeutic Use (212)
- Benzoates - Administration & Dosage (155)
- Aged (152)
- Benzimidazoles - Adverse Effects (125)
- Biological And Medical Sciences (124)
- Medical Sciences (122)
- Treatment Outcome (107)
- Triazoles - Adverse Effects (98)
- Adolescent (97)
- Pharmacology & Pharmacy (96)
- Hematology (94)
- Hydrazines - Adverse Effects (89)
-
More options
Databases
- MEDLINE (518)
- ProQuest Central (231)
- GFMER Free Medical Journals (132)
- PubMed Central (116)
- DOAJ Directory of Open Access Journals (93)
- HighWire Press (Free Journals) (59)
- ROAD: Directory of Open Access Scholarly Resources (59)
- Open Access: Wiley-Blackwell Open Access Journals (38)
- ProQuest One Psychology (30)
- Open Access: Nature Open Access (18)
- SpringerOpen (15)
- IngentaConnect Open Access (13)
- Taylor & Francis (Open access) (12)
- Dove Press Free (9)
- Sage Journals Open Access Journals (9)
- Open Access: Freely Accessible Journals by multiple vendors (8)
- Journals@Ovid Open Access Journal Collection Rolling (6)
- Public Library of Science (PLoS) Journals Open Access (6)
- Cochrane Library (Open Aceess) (5)
- Hyper Article en Ligne (HAL) (Open Access) (4)
-
More options
Language
Journal Title
- Annals Of Hematology (16)
- Blood (17)
- Clinical Therapeutics (13)
- Contact Dermatitis (46)
- European Journal Of Haematology (10)
- Haematologica (9)
- Hypertension Research (8)
- Journal Of Clinical Pharmacology (15)
- The Lancet (14)
- The New England Journal Of Medicine (14)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||